Transurethral seminal vesiculoscopy for recurrent hemospermia： experience from 419 cases
Transurethral seminal vesiculoscopy for recurrent hemospermia： experience from 419 cases作者机构：Department of Urology Shanghai Changhai Hospital Second Military Medical University Shanghai 200433 China Medical College of Chinese People's Liberation Army and Chinese People's Liberation Army General Hospital Beijing 100853 China
出 版 物：《Asian Journal of Andrology》 (亚洲男性学杂志（英文版）)
年 卷 期：2018年第20卷第5期
页 面：438-441页
核心收录：
学科分类：07[理学] 0905[农学-畜牧学] 09[农学] 070104[理学-应用数学] 090501[农学-动物遗传育种与繁殖] 0701[理学-数学]
基 金：funded by “Key Project of Shanghai Commission of Science and Technology”: Mechanism and clinical implication of dysfunction of the gonadal axis in climacteric man the “1255 Project” of the Second Military Medical University: Applied Anatomy of Seminal Tract
主 题：endoscopy hemospermia transurethral seminal vesiculoscopy
摘 要：We summarized our experience in transurethral seminal vesiculoscopy （TSV） for recurrent hemospermia by introducing surgical techniques, intraoperative findings, and treatment outcomes. TSV was performed in 419 patients with an initial diagnosis of persistent hemospermia at Shanghai Changhai Hospital （Shanghai, China） from May 2007 to November 2015. TSV was successfully performed in 381 cases （90.9%）. Hemospermia was alleviated or disappeared in 324 （85.0%） patients by 3 months after surgery. Common intraoperative manifestations were bleeding, obstruction or stenosis, mucosal lesions, and calculus. Endoscopic presentation of the ejaculatory duct orifice and the verumontanum was categorized into four types, including 8 （1.9%）, 32 （7.6%）, 341 （81.4%）, and 38 （9.1%） cases in Types A, B, C, and D, respectively. TSV is an effective and safe procedure in the management of seminal tract disorders. This study may help other surgeons to become familiar with and improve this procedure. However, further multicentric clinical trials are warranted to validate these findings.
维普期刊数据库